Non-Prescription Treatment Options

被引:1
|
作者
Francois, Sandy [1 ]
Felix, Kayla [2 ]
Cardwell, Leah [2 ]
Edwards, Taylor [3 ]
Rice, Zakiya [1 ]
机构
[1] Emory Sch Med, Dept Dermatol, Atlanta, GA 30307 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Dermatol, Winston Salem, NC 27103 USA
[3] Ohio Univ, Heritage Coll Osteopath Med, Athens, OH 45701 USA
关键词
Alternative treatment; Natural oils; Emollients; Textile; STRATUM-CORNEUM LIPIDS; ATOPIC-DERMATITIS; SKIN BARRIER; DOUBLE-BLIND; COCONUT OIL; ECZEMA; HYDROCORTISONE; EFFICACY; CREAM; CHILDREN;
D O I
10.1007/978-3-319-64804-0_11
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The pathogenesis of atopic dermatitis (AD) is complex and multifactorial. However, recent advancements in the genetics and pathophysiology of AD suggest that epidermal barrier dysfunction is paramount in the development and progression of the condition (Boguniewicz and Leung, Immunol Rev 242(1): 233-246, 2011). In addition to standard therapy for AD, there are a plethora of non-prescription treatment modalities which may be employed. Over-the-counter treatments for atopic dermatitis can come in the form of topical corticosteroids, moisturizers/emollients, and oral anti-histamines. Though these treatments are beneficial, prescription treatments may be quicker acting and more efficacious in patients with moderate to severe disease or during flares. OTC agents are best used for maintenance between flares and to prevent progression of mild disease. Alternative and complementary treatments lack strong efficacy evidence. However, wet wraps, bleach baths, and other treatments appear to be promising when used in conjunction with conventional treatments. With the financial burden of atopic dermatitis ranging from 364 million to 3.8 billion dollars each year in the United States, we suspect this topic will gain further research attention.
引用
收藏
页码:121 / 137
页数:17
相关论文
共 50 条
  • [41] Evidence-based guidelines for non-prescription treatment of vulvovaginal candidiasis (VVC)
    M.C. Watson
    C.M. Bond
    Pharmacy World and Science, 2003, 25 : 129 - 134
  • [42] Relationships between prescription and non-prescription drug use in an elderly population
    Poole, C
    Jones, D
    Veitch, B
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1999, 28 (03) : 259 - 271
  • [43] N-NITROSO COMPOUND CONTAMINANTS IN PRESCRIPTION AND NON-PRESCRIPTION DRUGS
    KRULL, IS
    GOFF, U
    SILVERGLEID, A
    FINE, DH
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (06): : 870 - 874
  • [44] Prescription Treatment Options
    Ackerson, Brad
    Thorpe, Ryan
    Nicholas, Matilda W.
    MANAGEMENT OF ATOPIC DERMATITIS: METHODS AND CHALLENGES, 2017, 1027 : 105 - 120
  • [45] Risk of Unintentional Overdose with Non-Prescription Acetaminophen Products
    Wolf, Michael S.
    King, Jennifer
    Jacobson, Kara
    Di Francesco, Lorenzo
    Bailey, Stacy Cooper
    Mullen, Rebecca
    McCarthy, Danielle
    Serper, Marina
    Davis, Terry C.
    Parker, Ruth M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 (12) : 1587 - 1593
  • [46] TELEVISION ADVERTISING OF NON-PRESCRIPTION MEDICINES - CASE FOR DEFENDANT
    COPE, JD
    JOURNAL OF DRUG ISSUES, 1976, 6 (01) : 85 - 90
  • [47] How and why are non-prescription analgesics used in Scotland?
    Porteous, T
    Bond, C
    Hannaford, P
    Sinclair, H
    FAMILY PRACTICE, 2005, 22 (01) : 78 - 85
  • [48] The use of non-prescription medicines by general practitioner attendees
    Urquhart, G
    Sinclair, HK
    Hannaford, PC
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (11) : 773 - 779
  • [49] Non-prescription use in a sample of women with breast cancer
    Catt, S
    Fallowfield, L
    Langridge, C
    PSYCHO-ONCOLOGY, 2005, 14 (12) : 1084 - 1084
  • [50] Switch - The German process for moving medicines from prescription to non-prescription status
    Kroth, Elmar
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2018, 23 (02): : 97 - 102